The global Bioinformatics market is projected to grow from USD 18.63 billion in 2026 to USD 34.41 billion by 2031, at a CAGR of 13.1% during the forecast period. The market was valued at USD 16.70 billion in 2025. The growth of the bioinformatics market is driven by the rising adoption of next-generation sequencing (NGS) technologies, increasing incorporation of artificial intelligence (AI) and machine learning (ML) into biological data analysis, growing investments in precision medicine and omics research, and the increasing demand for cloud-based bioinformatics tools.
Growth in the market is also supported by expanding R&D activities across the pharmaceutical and biotechnology sectors and the increasing application of bioinformatics in drug discovery, biomarker detection, clinical trials, genomics, and other life sciences research workflows. The growing volume and complexity of biological data is further increasing demand for advanced bioinformatics platforms capable of processing, integrating, analyzing, and interpreting large-scale genomic and molecular datasets.
Spotlights on the Industry’s Leading Bioinformatics Companies
The bioinformatics industry is evolving rapidly as pharmaceutical companies, biotechnology organizations, academic institutions, and research laboratories seek advanced technologies to convert complex biological data into actionable insights. Companies operating in this market are developing solutions spanning genomic data analysis, NGS informatics, cloud computing, AI-powered analytics, multi-omics, drug discovery, data management, and computational biology.
1. Thermo Fisher Scientific Inc. (US)
Thermo Fisher Scientific provides a broad portfolio of life sciences technologies, sequencing solutions, instruments, reagents, and software supporting bioinformatics workflows. Its solutions enable researchers to generate, analyze, and interpret genomic and molecular data across research and clinical applications.
The company’s technologies support NGS, molecular biology, genomics, and applied research, contributing to the growing need for integrated bioinformatics solutions as biological datasets become increasingly complex.
2. Illumina, Inc. (US)
Illumina is a major provider of sequencing and genomics technologies, with platforms and informatics solutions supporting the generation and analysis of large-scale genomic datasets. Its technologies are used across research, clinical genomics, oncology, reproductive health, and population genomics.
The increasing adoption of NGS is driving demand for bioinformatics tools capable of processing sequencing data, identifying genomic variants, and supporting downstream biological interpretation.
3. QIAGEN N.V. (Netherlands)
QIAGEN provides molecular biology, sample preparation, bioinformatics, and data analysis solutions for life sciences and molecular diagnostics applications. Its bioinformatics portfolio supports genomic data analysis, interpretation, and workflow management.
The company’s solutions help researchers and healthcare organizations translate molecular data into actionable insights across applications such as infectious disease, oncology, precision medicine, and genomics research.
4. Agilent Technologies, Inc. (US)
Agilent Technologies provides analytical instruments, genomics technologies, software, and laboratory solutions supporting life sciences research. Its portfolio addresses applications involving sequencing, molecular analysis, and biological data interpretation.
The growing use of genomics and multi-omics research is increasing demand for analytical and bioinformatics technologies that can support complex biological datasets and improve research efficiency.
5. F. Hoffmann-La Roche Ltd. (Switzerland)
F. Hoffmann-La Roche provides diagnostic, sequencing, and digital technologies supporting genomics, molecular diagnostics, and personalized healthcare. Its solutions contribute to the analysis and interpretation of biological and clinical data.
The company’s focus on precision medicine and molecular diagnostics supports the growing integration of bioinformatics into clinical research, biomarker discovery, and disease characterization.
6. Revvity, Inc. (US)
Revvity provides life sciences technologies, software, and solutions supporting genomics, proteomics, imaging, and drug discovery research. Its platforms enable researchers to generate and analyze complex biological datasets.
The integration of advanced analytics and computational tools into life sciences workflows is creating opportunities for bioinformatics solutions that can improve data interpretation and accelerate research.
7. Eurofins Scientific (Luxembourg)
Eurofins Scientific provides laboratory testing, genomics, bioinformatics, and analytical services across pharmaceutical, biotechnology, clinical, and research applications. Its genomics capabilities support sequencing and biological data analysis.
The company’s broad testing and laboratory network enables the use of bioinformatics across applications such as genomics, molecular diagnostics, biomarker research, and drug development.
8. BGI Genomics (China)
BGI Genomics provides genomic sequencing, bioinformatics, and data analysis services for research, healthcare, and life sciences applications. Its capabilities span large-scale sequencing and interpretation of genomic information.
The company’s extensive genomics activities support applications in population genomics, disease research, reproductive health, oncology, and precision medicine.
9. Waters Corporation (US)
Waters Corporation provides analytical technologies, informatics, and laboratory solutions supporting pharmaceutical, biotechnology, and life sciences research. Its platforms facilitate the generation and analysis of complex molecular data.
Bioinformatics and computational analysis are increasingly important in integrating analytical datasets, particularly across applications involving metabolomics, proteomics, and drug discovery.
10. DNAnexus, Inc. (US)
DNAnexus provides cloud-based data management, bioinformatics, and genomic analysis solutions. Its platform enables organizations to securely manage, process, analyze, and collaborate on large-scale genomic datasets.
The growing adoption of cloud computing in genomics is increasing demand for scalable bioinformatics platforms capable of supporting distributed research teams, large sequencing projects, and complex analytical workflows.
11. Oxford Nanopore Technologies plc. (UK)
Oxford Nanopore Technologies develops sequencing technologies capable of generating real-time genomic data. Its sequencing platforms are supported by computational and bioinformatics workflows for data processing and interpretation.
The company’s technologies enable applications across genomics, infectious disease, environmental research, and precision medicine, where rapid sequencing and analysis can provide valuable biological insights.
12. 10x Genomics (US)
10x Genomics develops technologies for single-cell and spatial biology research, generating high-dimensional biological datasets that require sophisticated computational analysis.
Its platforms support applications such as single-cell genomics, spatial transcriptomics, immune profiling, and tissue analysis, contributing to the growing demand for bioinformatics solutions capable of handling complex multi-dimensional datasets.
13. PacBio (US)
PacBio provides long-read sequencing technologies and associated informatics solutions for genomic research. Its platforms enable researchers to analyze complex genomes, structural variants, transcripts, and other biological features.
The increasing use of long-read sequencing is expanding the need for specialized bioinformatics tools capable of processing and interpreting high-quality long-read datasets.
14. Dotmatics (US)
Dotmatics provides scientific R&D software and data management solutions designed to connect scientific information across research workflows. Its platforms support data analysis, visualization, collaboration, and research informatics.
The integration of scientific data across genomics, drug discovery, and life sciences research creates opportunities for advanced bioinformatics and data management technologies.
15. SOPHiA GENETICS (US)
SOPHiA GENETICS provides data-driven technologies for genomic analysis, with platforms designed to support the interpretation of complex genomic data in healthcare and research.
Its solutions apply advanced analytics and AI-enabled approaches to genomic information, supporting applications such as oncology, hereditary disease, and precision medicine.
16. Excelra (US)
Excelra provides data science, bioinformatics, and analytics solutions for pharmaceutical and biotechnology organizations. Its capabilities support drug discovery, biomarker research, biological data analysis, and knowledge management.
The company’s data-driven approach helps life sciences organizations extract insights from complex biological and scientific datasets to support research and development activities.
17. GENEWIZ (Azenta Life Sciences) (US)
GENEWIZ, part of Azenta Life Sciences, provides genomic services including sequencing, gene synthesis, molecular biology, and related data analysis solutions.
Its genomics services generate datasets that require bioinformatics processing and interpretation, supporting applications across academic research, biotechnology, pharmaceutical development, and molecular biology.
18. ONTOFORCE (Belgium)
ONTOFORCE provides data integration and knowledge management solutions designed to connect complex biomedical information. Its technologies enable organizations to integrate scientific and healthcare datasets to improve data discovery and analysis.
The growing complexity of biomedical data is increasing demand for platforms capable of connecting heterogeneous datasets and enabling researchers to derive meaningful insights.
19. Velsera Inc. (US)
Velsera provides bioinformatics and data analysis solutions supporting genomic research and precision medicine. Its platforms enable researchers and healthcare organizations to manage and analyze genomic data throughout complex analytical workflows.
The company’s technologies support applications across clinical genomics, research, and personalized medicine, where scalable and reproducible bioinformatics workflows are increasingly important.
20. Seqera (Spain)
Seqera develops software and workflow technologies that support data-intensive life sciences research. Its platforms help researchers build, execute, manage, and scale computational workflows across local and cloud-based infrastructure.
The company’s solutions address the growing need for reproducible and scalable bioinformatics workflows as genomic datasets increase in volume and complexity.
Conclusion:
The bioinformatics market is experiencing strong growth as advances in NGS, AI, machine learning, cloud computing, precision medicine, and multi-omics continue to generate increasingly large and complex biological datasets. The expanding use of bioinformatics across drug discovery, biomarker detection, genomics, clinical trials, and pharmaceutical and biotechnology R&D is creating significant opportunities for data analysis and computational biology technologies.
For deeper insights into the Bioinformatics Market, including market size and growth, technology trends, applications, competitive landscape, regional opportunities, market segmentation, NGS adoption, AI and ML integration, cloud-based solutions, and growth prospects through 2031, access the complete market report.
